In adults, NFL levels have been shown to be elevated in most forms of neurodegenerative diseases and also to correlate with clinical progression in Alzheimer’s disease, frontotemporal dementia, and Parkinson’s disease [19]. This evidence concerns the gene NEFL and early-onset autosomal dominant Alzheimer disease.